SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-048914
Filing Date
2019-02-25
Accepted
2019-02-25 06:06:35
Documents
4
Period of Report
2019-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d711379d8k.htm 8-K 17762
2 EX-99.1 d711379dex991.htm EX-99.1 22551
3 GRAPHIC g711379g0223210320620.jpg GRAPHIC 3105
4 GRAPHIC g711379g0223210320745.jpg GRAPHIC 2378
  Complete submission text file 0001193125-19-048914.txt   49373
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 19627982
SIC: 2834 Pharmaceutical Preparations